Substance-induced psychosis

From Wikipedia, the free encyclopedia
Substance-induced psychosis
Classification and external resources
ICD-10 F10.5-F19.5
ICD-9 292.1
MeSH D011605

Substance-induced psychosis is a form of substance-related disorder where psychosis can be attributed to substance use. Various psychoactive substances have been implicated in causing or worsening psychosis in users.

Substances

Psychotic states may occur after using a variety of legal and illegal substances. Usually such states are temporary and not irreversible, with fluoroquinolone-induced psychosis being a notable exception. Drugs whose use, abuse, or withdrawal are implicated in psychosis include the following:

ICD-10

  • F10.5 alcohol:[1][2][3] Alcohol is a common cause of psychotic disorders or episodes, which may occur through acute intoxication, chronic alcoholism, withdrawal, exacerbation of existing disorders, or acute idiosyncratic reactions.[4] Research has shown that alcohol abuse causes an 8-fold increased risk of psychotic disorders in men and a 3 fold increased risk of psychotic disorders in women.[5][6] While the vast majority of cases are acute and resolve fairly quickly upon treatment and/or abstinence, they can occasionally become chronic and persistent.[4] Alcoholic psychosis is sometimes misdiagnosed as another mental illness such as schizophrenia.[7]
  • F12.5 cannabinoid: Some studies indicate that cannabis, especially certain strains containing large proportions of THC and low proportions of CBD,[8] may lower the threshold for psychosis, and thus help to trigger full-blown psychosis in some people.[9] Recent studies have found an increase in risk for psychosis in cannabis users.[10] It is not clear whether this is a causal link; it is possible that cannabis use only increases the risk of psychosis in people already predisposed to it.
  • F16.5 hallucinogens (LSD and others)

The code F11.5 is reserved for opioid-induced psychosis, and F17.5 is reserved for tobacco-induced psychosis, but neither substance is traditionally associated with the induction of psychosis.

The code F15.5 also includes caffeine-induced psychosis, despite not being specifically listed in the DSM-IV. However, there is evidence that caffeine, in extreme acute doses or when severely abused for long periods of time, may induce psychosis.[23][24]

Other

  • Synthetic research chemicals used recreationally, including:
    • JWH-018 and some other synthetic cannabinoids, or mixtures containing them (e.g. "Spice", "Kronic", "MNG" or "Mr. Nice Guy", "Relaxinol", etc.).[50] Various "JWH-XXX" compounds in "Spice" or "Incense" [51] have also been found.
    • Mephedrone and related amphetamine-like drugs sold as "bath salts" or "plant food".[52]

References

  1. Larson, Michael (2006-03-30). "Alcohol-Related Psychosis". eMedicine. WebMD. Retrieved September 27, 2006. 
  2. Soyka, Michael (March 1990). "Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia". Acta Psychiatrica Scandinavica 81 (3): 255–9. doi:10.1111/j.1600-0447.1990.tb06491.x. PMID 2343749. 
  3. Gossman, William (November 19, 2005). "Delirium Tremens". eMedicine. WebMD. Retrieved October 16, 2006. 
  4. 4.0 4.1 http://emedicine.medscape.com/article/289848-overview Alcohol-Related Psychosis
  5. Tien AY, Anthony JC (August 1990). "Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences". J. Nerv. Ment. Dis. 178 (8): 473–80. doi:10.1097/00005053-199017880-00001. PMID 2380692. 
  6. Cargiulo T (March 2007). "Understanding the health impact of alcohol dependence". Am J Health Syst Pharm 64 (5 Suppl 3): S5–11. doi:10.2146/ajhp060647. PMID 17322182. 
  7. Schuckit MA (November 1983). "Alcoholism and other psychiatric disorders". Hosp Community Psychiatry 34 (11): 1022–7. PMID 6642446. 
  8. THC and Psychosis from Neuropsychopharmacology 35, 764–774, dated 1 February 2010.
  9. Degenhardt L (January 2003). "The link between cannabis use and psychosis: furthering the debate". Psychological Medicine 33 (1): 3–6. doi:10.1017/S0033291702007080. PMID 12537030. 
  10. Moore TH, Zammit S, Lingford-Hughes A, et al. (July 2007). "Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review". Lancet 370 (9584): 319–28. doi:10.1016/S0140-6736(07)61162-3. PMID 17662880. 
  11. de Paola L, Mäder MJ, Germiniani FM, et al. (June 2004). "Bizarre behavior during intracarotid sodium amytal testing (Wada test): are they predictable?". Arquivos De Neuro-psiquiatria 62 (2B): 444–8. doi:10.1590/S0004-282X2004000300012. PMID 15273841. 
  12. Sarrecchia C, Sordillo P, Conte G, Rocchi G (1998). "[Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication]". Annali Italiani Di Medicina Interna (in Italian) 13 (4): 237–9. PMID 10349206. 
  13. White MC, Silverman JJ, Harbison JW (February 1982). "Psychosis associated with clonazepam therapy for blepharospasm". The Journal of Nervous and Mental Disease 170 (2): 117–9. doi:10.1097/00005053-198202000-00010. PMID 7057171. 
  14. Jaffe R, Gibson E (June 1986). "Clonazepam withdrawal psychosis". Journal of Clinical Psychopharmacology 6 (3): 193. doi:10.1097/00004714-198606000-00021. PMID 3711371. 
  15. Hallberg RJ, Lessler K, Kane FJ (August 1964). "Korsakoff-Like Psychosis Associated With Benzodiazepine Overdosage". The American Journal of Psychiatry 121: 188–9. PMID 14194223. 
  16. Hall RC, Zisook S (1981). "Paradoxical reactions to benzodiazepines". British Journal of Clinical Pharmacology 11 (Suppl 1): 99S–104S. PMC 1401636. PMID 6133541. 
  17. Lader M, Morton S. Benzodiazepine Problems. British Journal of Addiction 1991; 86: 823-828
  18. Benzodiazepines: Paradoxical Reactions & Long-Term Side-Effects
  19. Hansson O, Tonnby B. [Serious Psychological Symptoms Caused by Clonazepam.] Läkartidningen 1976; 73: 1210-1211.
  20. Pétursson H (November 1994). "The benzodiazepine withdrawal syndrome". Addiction 89 (11): 1455–9. doi:10.1111/j.1360-0443.1994.tb03743.x. PMID 7841856. 
  21. Brady, K. T.; R. B. Lydiard, R. Malcolm, and J. C. Ballenger (December 1991). "Cocaine-induced psychosis". Journal of Clinical Psychiatry 52 (12): 509–512. PMID 1752853. 
  22. 22.0 22.1 22.2 Diaz, Jaime. How Drugs Influence Behavior. Englewood Cliffs: Prentice Hall, 1996.
  23. Hedges DW, Woon FL, Hoopes SP (March 2009). "Caffeine-induced psychosis". CNS Spectrums 14 (3): 127–9. PMID 19407709. 
  24. Cerimele JM, Stern AP, Jutras-Aswad D (March 2010). "Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia". The American Journal of Psychiatry 167 (3): 353. doi:10.1176/appi.ajp.2009.09101456. PMID 20194494. 
  25. Cohen JS (December 2001). "Peripheral Neuropathy Associated with Fluoroquinolones" (PDF). Ann Pharmacother 35 (12): 1540–7. doi:10.1345/aph.1Z429. PMID 11793615. 
  26. Adams M, Tavakoli H (2006). "Gatifloxacin-induced hallucinations in a 19-year-old man". Psychosomatics 47 (4): 360. doi:10.1176/appi.psy.47.4.360. PMID 16844899. 
  27. Mulhall JP, Bergmann LS (July 1995). "Ciprofloxacin-induced acute psychosis". Urology 46 (1): 102–3. doi:10.1016/S0090-4295(99)80171-X. PMID 7604468. 
  28. Reeves RR (1992). "Ciprofloxacin-induced psychosis". Ann Pharmacother 26 (7–8): 930–1. PMID 1504404. 
  29. Yasuda H, Yoshida A, Masuda Y, Fukayama M, Kita Y, Inamatsu T (March 1999). "[Levofloxacin-induced neurological adverse effects such as convulsion, involuntary movement (tremor, myoclonus and chorea like), visual hallucination in two elderly patients]". Nippon Ronen Igakkai Zasshi (in Japanese) 36 (3): 213–7. doi:10.3143/geriatrics.36.213. PMID 10388331. 
  30. Azar S, Ramjiani A, Van Gerpen JA (April 2005). "Ciprofloxacin-induced chorea". Mov. Disord. 20 (4): 513–4; author reply 514. doi:10.1002/mds.20425. PMID 15739219. 
  31. Kukushkin ML, Igonkina SI, Guskova TA (April 2004). "Mechanisms of pefloxacin-induced pain". Bull. Exp. Biol. Med. 137 (4): 336–8. doi:10.1023/B:BEBM.0000035122.45148.93. PMID 15452594. 
  32. Christie MJ, Wong K, Ting RH, Tam PY, Sikaneta TG (May 2005). "Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure". Ann Pharmacother 39 (5): 953–5. doi:10.1345/aph.1E587. PMID 15827068. 
  33. Marsepoil T, Petithory J, Faucher JM, Ho P, Viriot E, Benaiche F (1993). "[Encephalopathy and memory disorders during treatments with mefloquine]". Rev Med Interne (in French) 14 (8): 788–91. doi:10.1016/S0248-8663(05)81426-2. PMID 8191092. 
  34. Phillips-Howard PA, ter Kuile FO (June 1995). "CNS adverse events associated with antimalarial agents. Fact or fiction?". Drug Saf 12 (6): 370–83. doi:10.2165/00002018-199512060-00003. PMID 8527012. 
  35. Price, L. H.; Lebel, J. (2000). "Dextromethorphan-Induced Psychosis". American Journal of Psychiatry 157 (2): 304. doi:10.1176/appi.ajp.157.2.304. PMID 10671422. 
  36. Lachover, L. (2007). "Deciphering a Psychosis: A Case of Dextromethorphan-Induced Symptoms". Primary Psychiatry 14 (1): 70–72. 
  37. Sexton, J. D.; Pronchik, D. J. (1997). "Diphenhydramine-induced psychosis with therapeutic doses". The American Journal of Emergency Medicine 15 (5): 548–549. doi:10.1016/S0735-6757(97)90212-6. PMID 9270406. 
  38. Lang, K.; Sigusch, H.; Müller, S. (1995). "Anticholinergisches Syndrom mit halluzinatorischer Psychose nach Diphenhydramin-Intoxikation" [An anticholinergic syndrome with hallucinatory psychosis after diphenhydramine poisoning]. Deutsche Medizinische Wochenschrift (in German) 120 (49): 1695–1698. doi:10.1055/s-2008-1055530. PMID 7497894. 
  39. Schreiber, W.; Pauls, A. M.; Krieg, J. C. (1988). "Toxische Psychose als Akutmanifestation der Diphenhydraminvergiftung" [Toxic psychosis as an acute manifestation of diphenhydramine poisoning]. Deutsche Medizinische Wochenschrift (in German) 113 (5): 180–183. doi:10.1055/s-2008-1067616. PMID 3338401. 
  40. Timnak, C.; Gleason, O. (2004). "Promethazine-Induced Psychosis in a 16-Year-Old Girl". Psychosomatics 45 (1): 89–90. doi:10.1176/appi.psy.45.1.89. PMID 14709767. 
  41. Gunn, V. L.; Taha, S. H.; Liebelt, E. L.; Serwint, J. R. (2001). "Toxicity of Over-the-Counter Cough and Cold Medications". Pediatrics 108 (3): e52. doi:10.1542/peds.108.3.e52. 
  42. Hall, R. C.; Popkin, M. K.; Stickney, S. K.; Gardner, E. R. (1979). "Presentation of the steroid psychoses". The Journal of Nervous and Mental Disease 167 (4): 229–236. doi:10.1097/00005053-197904000-00006. PMID 438794. 
  43. Bergman, K. R.; Pearson, C.; Waltz, G. W.; Evans R. III (1980). "Atropine-induced psychosis. An unusual complication of therapy with inhaled atropine sulfate". Chest 78 (6): 891–893. doi:10.1378/chest.78.6.891. PMID 7449475. 
  44. Varghese, S.; Vettath, N.; Iyer, K.; Puliyel, J. M.; Puliyel, M. M. (1990). "Ocular atropine induced psychosis--is there a direct access route to the brain?". Journal of the Association of Physicians of India 38 (6): 444–445. PMID 2384469. 
  45. Barak, Segev; Weiner, I. (2006). "Scopolamine Induces Disruption of Latent Inhibition Which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor". Neuropsychopharmacology 32 (5): 989–999. doi:10.1038/sj.npp.1301208. PMID 16971898. 
  46. Carey, R. J.; Pinheiro-Carrera, M.; Dai, H.; Tomaz, C.; Huston, J. P. (1995). "l-DOPA and psychosis: Evidence for l-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone". Biological Psychiatry 38 (10): 669–676. doi:10.1016/0006-3223(94)00378-5. PMID 8555378. 
  47. Ettinger, A. B. (2006). "Psychotropic effects of antiepileptic drugs". Neurology 67 (11): 1916–1925. doi:10.1212/01.wnl.0000247045.85646.c0. PMID 17159095. 
  48. http://www.erowid.org/references/refs_view.php?A=ShowDoc1&ID=526 'Ecstasy' Psychosis and Flashbacks F.J. CREIGHTON,D. L. BLACK and C. E. HYDE
  49. http://www.minddisorders.com/Py-Z/Substance-induced-psychotic-disorder.html Substance-induced psychotic disorder
  50. http://www.airforcetimes.com/news/2011/06/air-force-spice-users-risk-psychosis-says-doctor-061111w/ Spice users risk psychosis, doctor says By Gidget Fuentes - Staff writer Accessed 06-25-2011
  51. http://en.wikipedia.org/wiki/Synthetic_cannabis
  52. http://www.addictions.com/bath-salt-addiction Bath Salt Addiction, Accessed 06-25-2011
  53. Kurzbaum, Alberto; Claudia Simsolo, Ludmilla Kvasha and Arnon Blum (July 2001). "Toxic Delirium due to Datura Stramonium" (PDF). Israel Medical Association Journal 3 (7): 538–539. PMID 11791426. Retrieved 2006-10-17. 
  54. Przekop, Peter; Timothy Lee (July 2009). "Persistent Psychosis Associated With Salvia Divinorum Use". American Journal of Psychiatry 166 (832): 832. doi:10.1176/appi.ajp.2009.08121759. PMID 19570943. Retrieved 2010-05-14. 
  55. Tarsh, M.J. (1979). "Schizophreniform Psychosis caused by Sniffing Toluene" (PDF). Journal of the Society for Occupational Medicine 1979 (29): 131–133. doi:10.1093/occmed/29.4.131. Retrieved 2010-05-14. 
  56. Rao, Naren P.; Arun Gupta, K. Sreejayan, Prabhat K. Chand, Vivek Benegal, and Pratima Murthy (2009). "Toluene associated schizophrenia-like psychosis". Indian Journal of Psychiatry 51 (4): 329–330. doi:10.4103/0019-5545.58307. PMC 2802388. PMID 20048466. 
  57. Jung IK, Lee HJ, Cho BH (December 2004). "Persistent psychotic disorder in an adolescent with a past history of butane gas dependence". European Psychiatry 19 (8): 519–20. doi:10.1016/j.eurpsy.2004.09.010. PMID 15589716. 
  58. Hernandez-Avila, Carlos A.; Hector A. Ortega-Soto, Antonio Jasso, Cecilia A. Hasfura-Buenaga, and Henry R. Kranzler (1998). "Treatment of Inhalant-Induced Psychotic Disorder With Carbamazepine Versus Haloperidol". Psychiatric Services 49 (6): 812–815. PMID 9634163. Retrieved 2010-05-28. 
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.